SOFT Yields Hard Data on Hormone TherapySOFT Yields Hard Data on Hormone Therapy
Drs Kathy Miller and Ann Partridge drill down on the practice-changing data from the SOFT trial, indicating which breast cancer patients should receive ovarian suppression. Medscape Oncology
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news
More News: Breast Cancer | Cancer | Cancer & Oncology | Hematology | Hormonal Therapy | Hormones | Ovarian Cancer | Ovaries